Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2014
10/02/2014US20140294884 Meningococcus adhesins nada, app and orf 40
10/02/2014US20140294857 Methods of obtaining a specific binding member that binds eotaxin
10/02/2014US20140294835 Novel heterodimeric proteins
10/02/2014US20140294819 Canine/feline cd20 binding epitope and compositions for binding thereto
10/02/2014US20140294762 Glycopegylation methods and proteins/peptides produced by the methods
10/01/2014EP2784160A1 Novel gene derived from mud flat metagenome and novel protein obtained therefrom showing coactivity of phospholipase and lipase
10/01/2014EP2784155A1 Adenovirus producing novel cell line and the use thereof
10/01/2014EP2784087A1 Recombinant baculovirus and use thereof
10/01/2014EP2784080A1 Peptide-hinge-free flexible antibody-like molecule
09/2014
09/30/2014US8847012 Genes that increase plant oil and method for using the same
09/30/2014US8847011 Genes that increase plant oil and method for using the same
09/30/2014US8846893 Non-ionically bound constructs, and compositions and kits comprising domains
09/30/2014US8846888 Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same
09/30/2014US8846886 Lepidopteran insect N-acetylglucosaminidase genes and their use in glycoengineering
09/30/2014US8846876 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
09/30/2014US8846868 Anti-AREG/HB-EGF antibodies and treatment
09/30/2014US8846866 Aldehyde tags, uses thereof in site-specific protein modification
09/30/2014US8846385 Method and means for producing high titer, safe recombinant lentivirus vectors
09/30/2014US8846383 Method for the biotechnological production of valuable products
09/30/2014US8846369 Cyanobacterium sp. host cell and vector for production of chemical compounds in cyanobacterial cultures
09/30/2014US8846362 Variant LOVD polypeptides and their uses
09/30/2014US8846354 Microorganisms for producing organic acids
09/30/2014US8846352 Genetically engineered microorganisms that metabolize xylose
09/30/2014US8846348 Kits and methods for generating 5′ capped RNA
09/30/2014US8846346 Detection of soluble adiponectin receptor peptides and use in diagnosis and therapeutics
09/30/2014US8846343 High-expression promoter derived from Kluyveromyces marxianus
09/30/2014US8846341 Marker panels for idiopathic pulmonary fibrosis diagnosis and evaluation
09/30/2014US8846324 In vitro method for diagnosing or predicting hypertension and/or early-stage cardiovascular end-organ damage by determining the concentration of soluble prorenin receptor
09/30/2014US8846041 Anti-LRP6 antibodies
09/30/2014CA2606102C Modulation of antibody effector function by hinge domain engineering
09/30/2014CA2590935C Fc.gamma.riib-specific antibodies and methods of use thereof
09/30/2014CA2575769C Novel strains belonging to the genus paenibacillus and method of controlling plant disease by using these strains or culture thereof
09/30/2014CA2506737C Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll)
09/30/2014CA2471551C Methods to engineer mammalian-type carbohydrate structures
09/30/2014CA2285426C Detection of molecular interactions by reporter subunit complementation
09/25/2014WO2014153381A1 Alpha-lactalbumin enriched whey protein compositions and methods of making and using them
09/25/2014WO2014153217A1 Amino acids produced according to a process of mechanocatalytic hydrolysis of proteins
09/25/2014WO2014152832A1 Methods for in vitro memory b cell differentiation and transduction with vsv-g pseudotyped viral vectors
09/25/2014WO2014152715A1 Use of inhibitors of binding between a par-1 receptor and its ligands for the treatment of glioma
09/25/2014WO2014152145A1 Methods for producing antibodies
09/25/2014WO2014152100A1 Methods of producing antibodies in yeast
09/25/2014WO2014151683A1 Gla domains as targeting agents
09/25/2014WO2014151438A1 Multispecific anti-cd37 antibodies and related compositions and methods
09/25/2014WO2014148444A1 ANTI-DOG IgE MONOCLONAL ANTIBODY, AND LIGHT-CHAIN VARIABLE REGION AND HEAVY-CHAIN VARIABLE REGION OF ANTI-DOG IgE MONOCLONAL ANTIBODY
09/25/2014WO2014147873A1 Antibody that binds specifically with hmgb1 decomposition product, and method and reagent for assaying hmgb1 decomposition product
09/25/2014US20140288283 Truncated l1 protein of human papillomavirus type 6
09/25/2014US20140288161 Urocortin-iii and uses thereof
09/25/2014US20140287494 Mesendoderm and mesoderm cell populations
09/25/2014US20140287467 Processing biomass
09/25/2014US20140287466 Process for the conversion of lignocellulose material into an organic acid
09/25/2014US20140287463 Engineered pichia strains with improved fermentation yield and n-glycosylation quality
09/25/2014US20140287462 Gene inactivated mutants with altered protein production
09/25/2014US20140287460 Production of recombinant protein in insect cells using a baculovirus expression system
09/25/2014US20140287459 Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
09/25/2014US20140287457 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
09/25/2014US20140286977 Protein F - A Novel Haemophilus Influenzae Adhesin with Laminin and Vitronectin binding Properties
09/25/2014US20140286936 Anti-human cxcr4 antibodies
09/24/2014EP2781601A1 Method for producing insoluble aggregate of neurodegenerative-disease-related protein
09/24/2014EP2780463A1 Fc CONTAINING POLYPEPTIDES HAVING INCREASED ANTI-INFLAMMATORY PROPERTIES AND INCREASED FcRN BINDING
09/24/2014EP2780462A1 Engineered pichia strains with improved fermentation yield and n-glycosylation quality
09/24/2014EP2780033A1 Methods of treating cancer
09/23/2014US8841428 Polynucleotide nanomechanical device that acts as an artificial ribosome and translates DNA signals into polymer assembly instructions
09/23/2014US8841427 Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof
09/23/2014US8841420 Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with Porphyromonas gingivalis
09/23/2014US8841416 Therapeutic nuclease compositions and methods
09/23/2014US8841126 Method for gene transfer
09/23/2014US8841110 Animal product free system and process for purifying a botulinum toxin
09/23/2014US8841090 L-arabinose fermenting yeast
09/23/2014US8841089 Polynucleotides for enhancing expression of a polynucleotide of interest
09/23/2014US8841088 Method for mRNA stabilization
09/23/2014US8840939 Vigna unguiculata seed extract and compositions containing same
09/23/2014CA2691357C Antibodies to human programmed death receptor pd-1
09/23/2014CA2666308C Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
09/23/2014CA2658231C Method of producing recombinant tat-hoxb4h protein for use as a stimulant of hematopoiesis in vivo
09/23/2014CA2525975C Humanized antibodies that recognize beta amyloid peptide
09/18/2014WO2014145654A1 Method for the site-specific covalent cross-linking of antibodies to surfaces
09/18/2014WO2014145650A1 Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
09/18/2014WO2014145521A2 Fermentation process for antibody production
09/18/2014WO2014145441A1 Sortase-mediated protein purification and ligation
09/18/2014WO2014144288A1 Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
09/18/2014WO2014144061A2 Flavivirus neutralizing antibodies and methods of use thereof
09/18/2014WO2014144060A1 Monoclonal antibodies to transferrin and transferrin receptor antigens, and uses thereof
09/18/2014WO2014143343A1 Hcv core lipid binding domain monoclonal antibodies
09/18/2014WO2014142182A1 Monoclonal antibody inhibiting enzymatic activity of endothelial lipase
09/18/2014WO2014142117A1 Anti-staphylococcus antibody, method for manufacturing same, and usage of same
09/18/2014WO2014141304A1 Process for the production of cyclosporin-a using the fungus tolypocladium sp. strain nrrl no. :18950
09/18/2014WO2014141151A1 Use of tricarboxylic acid (tca) intermediates to control ammonia generation in cell culture
09/18/2014WO2014140391A1 Use of garvicin a as an antimicrobial product
09/18/2014WO2014139994A1 Growth hormone compounds
09/18/2014US20140274912 Methods of cell culture
09/18/2014US20140274911 Methods of cell culture
09/18/2014US20140274903 Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
09/18/2014US20140274893 Methods and Acellular Compositions For Treating Inflammatory Disorders
09/18/2014US20140273097 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (fut8) gene expression
09/18/2014US20140273095 Serum-Free Cell Culture Medium
09/18/2014US20140273090 Methods and Systems for Peptide/Protein Amplification
09/18/2014US20140273057 Methods of cell culture
09/18/2014US20140271622 Methods of cell culture
09/18/2014US20140271577 Human lysosomal proteins from plant cell culture
09/17/2014EP2776570A2 Food protein ingredient and methods for producing
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 1125